Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-001752

Options or other derivatives

  • Chief Medical Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Detke Michael J. · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 1 in the form Stock Option (right to buy) +125,000 125,000 D
Loading xslF345X03/doc4.xml…